SCHEMBL10558554

SCHEMBL10558554

CC(=O)N1CC(C)(C)c2cc3nc(-c4ccccc4)[nH]c3cc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.49
CHEK2 O96017 4/20 0.44
RAB9A P51151 6/20 0.41
NPC1 O15118 5/20 0.41
MAPT P10636 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
NPBWR1 P48145 3/20 0.41
HDAC6 Q9UBN7 2/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
KDM4E B2RXH2 5/20 0.40
ALDH1A1 P00352 5/20 0.40
HPGD P15428 5/20 0.40
TP53 P04637 3/20 0.40
HSD17B10 Q99714 3/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10556923 0.85 NOTUM (0.40) NOTUMRAB9ANPC1MAPTSMN1; SMN2
SCHEMBL10556449 0.77 KDM4E (0.42) NOTUMMAPTSMN1; SMN2KDM4EALDH1A1
SCHEMBL10642049 0.76 NPC1 (0.36) NOTUMCHEK2RAB9ANPC1HDAC6
SCHEMBL10559142 0.75 CDK4 (0.41) NOTUMMAPTSMN1; SMN2NPBWR1SCD
SCHEMBL10555632 0.72 NOTUM (0.47) NOTUMRAB9AMAPTSMN1; SMN2HDAC6
SCHEMBL10557907 0.72 NOTUM (0.51) NOTUMKDM4EALDH1A1CYP3A4
SCHEMBL15563980 0.70 NPC1 (0.51) CHEK2RAB9ANPC1MAPTSMN1; SMN2
Hydrochloric Acid SCHEMBL10555631 0.69 NPC1 (0.46) CHEK2RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL9866893 0.68 MMP2 (0.56) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL10375588 0.68 PDE4A (0.71) CHEK2RAB9ANPC1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4863945-A CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1989-09-05 US disclosed
EP-0271040-A2 Pyrrolobenzimidazoles, process for their preparation, and medicaments Roche Diagnostics GmbH (DE) 1988-06-15 EP disclosed